Comparison of eye movement desensitization and reprocessing with citalopram in treatment of obsessive–compulsive disorder

References

• Bjorqvinsson T, Hart J, Heffelfinger S. Obsessive compulsive disorder: update on assessment and treatment . J Psychiatr Pract 2007;13:362–72.
   PubMedGoogle Scholar
• Gava I, Barbui C, Aguglia E, Carlino D, Churchill R, Devanna M, . Psychological treatment versus treatment as usual for obsessive compulsive disorder. Cochrane Database of Systematic Reviews 2.
   Google Scholar
• Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, . Long-term course and outcome of obsessive compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo. Eur Arch Psychiatry Clin Neurosci 2005;225:121–8.
   Google Scholar
• Caulfield C. Obsessive compulsive disorder. Book reviews. Br J Psychiatry 2002;180:289–90.
   Google Scholar
• Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000;1:92–100.
   PubMedGoogle Scholar
• Dolatabadi SH. The presentation of EMDR and the comparison of EMDR efficacy with standard desensitization (SD) in treatment of distressful memories. PhD Thesis in general psychology; 1999.
   Google Scholar
• Mundo E, Bianchi L, Bellodi L. Efficacy of Fluvoxamine, paroxetine and citalopram in the treatment of obsessive compulsive disorder: a single-blind study. J Clin Psychopharmacol 1997;17:267–71.
   PubMed Web of Science ®Google Scholar
• Mukaddes NM, Abali O, Kaynak N. Citalopram treatment of children and adolescent with obsessive–compulsive disorder: a preliminary report. Psychiatry Clin Neurosci 2003;57: 405–8.
   PubMedGoogle Scholar
• Fallon BA, Mathew SJ. Biological therapies of obsessive compulsive disorder. J Psychiatr Pract 2000; 6:113–28.
   PubMedGoogle Scholar
• Koran LM, Bullock KD, Hartstan HJ, Elliott MA, D’Andrea V. Citalopram treatment of compulsive shoping: an open-label study. J Clin Psychiatry 2002;63:704–8.
   PubMed Web of Science ®Google Scholar
• Marazziti D, Dellossol A, Gemignani A, Ciapparelli A, Presta S, Nasso ED, . Citalopram in refractory obsessive compulsive disorder: an open study. Int Clin Psychopharmacol 2001; 16:215–90.
   PubMedGoogle Scholar
• Montgomery SA, Kaspers D, Stein DJ, Banghedegaard K, Lemming OM. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive compulsive disorder. Int Clin Psychopharmacol 2001;16: 75–86.
   PubMed Web of Science ®Google Scholar
• Pallanti S, Quercioli L, Koran LM. Citalopram intravenous in fusion in resistant obsessive–compulsive disorder: an open trial. J Clin Psychiatry 2002;63:796–801
   PubMed Web of Science ®Google Scholar
• Pallanti S, Hollander E, Goodman WK. A qualitative analysis of nonresponse: management of treatment refractory obsessive compulsive disorder. J Clin Psychiatry 2004;65:6–10.
   PubMedGoogle Scholar
• Thomsen PH. Child and adolescent obsessive–compulsive disorder treated with Citalopram : finding from an open trial of 23 cases. J Child Adolesc Psychopharmacol 1997;7:157–66.
   PubMed Web of Science ®Google Scholar
• Pallanti S, Quercioli L, Paiva RS, Koran LM. Citalopram for treatment-resistant obsessive–compulsive disorder. Eur Psychiatry 1999;14:101–6
   PubMed Web of Science ®Google Scholar
• Stein DJ, Montgomery SA, Kasper S, Tanghoj P. Predictors of response to pharmacotherapy with citalopram in obsessive–compulsive disorder. Int Clin Psychopharmacol 2001; 16:357–61
   PubMed Web of Science ®Google Scholar
• Thomsen PH, Ebbesen C, Persson C. Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 2001;40:895–902
   PubMed Web of Science ®Google Scholar
• Dadsetan P. Developmental psychopathology from infancy through adulthood. Vol 1. Tehran: SAMT; 2000. 148–77.
   Google Scholar
• Goodman WK, Lydiard RB. Recognition and treatment of obsessive compulsive disorder. J Clin Psychiatry 2007;68:30.
   Google Scholar
• Simpson HB, Foa EB, Liebouitz MR, Ledley DR, Huppert JD, Cahill S, . Randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive compulsive disorder. J Am Psychiatry 2008;165:621–30.
   PubMed Web of Science ®Google Scholar
• Garcia AM, Sapyta JJ, Moore PS, Freeman JB, Franklin ME, March JS, . Predictors and moderators of treatment outcome in the pediatric obsessive–compulsive treatment study. J Am Acad Child Adolesc Psychiatry 2010;49:1024–33
   PubMed Web of Science ®Google Scholar
• lteyman I . Challenges in child and adolescent with obsessive–compulsive disorder. J Psychiatry 2005;4:73–7.
   Google Scholar
• Jongh DA, Broeke TE. Treatment of chocking phobia by targeting traumatic memories with EMDR: A case study. J Clin Psychl Psychother 1998:5:264–9.
   Google Scholar
• Shapiro F. Eye movement desensitization and reprocessing. 1st. New York: The Guilford press; 1995.
   Google Scholar
• Carrigan MH, Levis DJ. The contributions of eye movements to the efficacy of brief exposure treatment for reducing fear of public speaking. J Anxiety Dis 1999;13:101–18.
   PubMed Web of Science ®Google Scholar
• Goldestein AJ, B Eurs ED, Chambless DL, Wilson KA. EMDR for panic disorder with agoraphobia comparison with waiting list and credible attention-placebo control conditions. J Consult Clin Psychol 2000;68:947–56.
   PubMedGoogle Scholar
• Momeni N. A study of the effectiveness of eye movement desensitization and reprocessing in treatment of social phobia disorder. Degree thesis for MA in Clinical Psychology, Shahed University; 2005,
   Google Scholar
• Paulsen S. EMDR and OCD. Available from: http://www.behavior.net/bolforums/showthread.php?t = 376 (Accessed 13 June 2010).
   Google Scholar
• Barker RT, Barker SB. The use of EMDR in reducing presentation anxiety. J EMDR Pract Res 2007;1:108–10.
   Google Scholar
• Cvetek R. EMDR treatment of distressful experience that fail to meet the criteria for PTSD. J EMDR Pract Res 2008;1:2–14.
   Google Scholar
• Hoberg G, Pagani M, Sudin O, Soares J, Abergwistedt A, Tarnell B, . Treatment of posttraumatic stress disorder with eye movement desensitization and reprocessing. Outcome is stable in 35-month follow up. J Psychiatry 2008;1: 10–19.
   Google Scholar
• Muris P, Merckelbach H. Traumatic memories , eye movements, phobia, and panic. J Anxiety Dis 1999;13:209–23.
   PubMed Web of Science ®Google Scholar